UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044741
Receipt number R000050701
Scientific Title Low dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial
Date of disclosure of the study information 2021/07/02
Last modified on 2024/01/30 00:58:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Low dose Rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial

Acronym

Low dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial

Scientific Title

Low dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial

Scientific Title:Acronym

Low dose rectal diclofenac for prevention of Post-ESD Coagulation Syndrome(LOWER PECS): a randomized controlled trial

Region

Japan


Condition

Condition

Post-ESD coagulation syndrome

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the prevention effect of low dose rectal diclofenac for post-ESD coagulation syndrome(PECS).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incident rate of PECS.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Add a diclofenac sodium sup. (50mg) immediately after colorectal ESD once.

Interventions/Control_2

Perform a rectal examination immediately after colorectal ESD.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who are going to receive colorectal ESD for the neoplasm 20 mm in size or larger, except for the tumor located in the Rb
(rectum below the peritoneal reflection).
2) Patients who are 20 years old or older and 85 years old or younger.

Key exclusion criteria

1) major organ failure (Liver disease; Child-Pugh classification C, Renal disease; stage 4 or higher, Heart failure; NYHA classification 3 or higher).
2) Performance Status(ECOG) 3 or 4.
3) Patients who use steroids or NSAIDs regularly.
4) Patients with Visual analog scale (VAS) >20mm, WBC > 10000, or body temperature > 37.0 at the time before ESD.
5) Patients who are contraindicant to NSAIDs use.
6) Patients who are going to have ESD or EMR for multiple lesions simultaneously.
7) The cases of intraoperative perforation.
8) The patients who are judged by attending doctors as not suitable for this trial. If systolic blood pressure is under 70 mmHg, diclofenac sodium cannot be given to the patient.

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Naoya
Middle name
Last name Okada

Organization

Omori Red Cross Hospital

Division name

Department of gastroenterology

Zip code

143-8527

Address

4-30-1, Chuo, Ota ward, Tokyo, JAPAN

TEL

08065720512

Email

okdnya@gmail.com


Public contact

Name of contact person

1st name Naoya
Middle name
Last name Okada

Organization

Omori Red Cross Hospital

Division name

Department of gastroenterology

Zip code

143-8527

Address

4-30-1, Chuo, Ota ward, Tokyo, JAPAN

TEL

08065720512

Homepage URL


Email

okdnya@gmail.com


Sponsor or person

Institute

Omori Red Cross Hospital, Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Omori Red Cross Hospital

Address

4-30-1, Chuo, Ota ward, Tokyo, 143-8527 JAPAN

Tel

03-3775-3111

Email

okdnya@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 06 Month 02 Day

Date of IRB

2021 Year 05 Month 07 Day

Anticipated trial start date

2021 Year 06 Month 10 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2025 Year 12 Month 31 Day

Date analysis concluded

2026 Year 12 Month 31 Day


Other

Other related information

Since patient recruitment was limited due to the pandemic of COVID-19, we decided to extend the interval of data entry and patient follow-up. This content has been approved by the IRB in our institution.


Management information

Registered date

2021 Year 07 Month 02 Day

Last modified on

2024 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050701


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name